Aug 14, 2020
Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results
Jun 22, 2020
Lantheus Completes Merger with Progenics
Jun 05, 2020
2020 Paracetamol (Capsule, Liquid Suspension, Tablet) Industry Analysis
Jun 03, 2020
American Regent Introduces Estradiol Valerate Injection, USP­; AO Rated and Therapeutically Equivalent to Delestrogen®1, 2
May 26, 2020
Global Paracetamol Market Analysis 2020-2024, Featuring Vendor Profiles of Anhui BBCA Likang Pharmaceutical Co. Ltd., Mallinckrodt Plc, Meghmani Group and Zhejiang Kangle Pharmaceutical Co. Ltd
May 18, 2020
SaVida Health, an Outpatient Medical Practice for Opioid and Alcohol Addiction, now accepting patients from Downeast Maine.
May 15, 2020
Titan Pharmaceuticals Reports First Quarter 2020 Financial Results
Apr 28, 2020
PharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
Apr 16, 2020
Mayne Pharma Submits New Drug Application for E4/DRSP to the FDA
Apr 14, 2020
Velan Capital Agrees to Support Merger of Lantheus and Progenics
Apr 08, 2020
FDA Approves First Generic of a Commonly Used Albuterol Inhaler to Treat and Prevent Bronchospasm
Mar 27, 2020
Luye Pharma Continues to Deliver Strong Growth in 2019
Feb 28, 2020
HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
Feb 28, 2020
HUYA Bioscience International® Announces the Successful Completion of Phase 1 Trial of HBI-3000
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 28, 2020
FDA approves GSK's Advil Dual Action with Acetaminophen for over-the-counter use in the United States
Feb 17, 2020
PharmaMar and Jazz Pharmaceuticals Announce FDA Acceptance and Priority Review of New Drug Application for Lurbinectedin in Relapsed Small Cell Lung Cancer
Feb 13, 2020
Drug Makers Focusing on Pain Management Alternatives to Opioid Drugs
Feb 12, 2020
Worldwide Prevalence of Opioid Use Disorders, 2019-2029 - Quantify Patient Populations to Target the Development of Future Products, Pricing Strategies and Launch Plans
Jan 22, 2020
PharmaMar and Jazz Pharmaceuticals Announce the U.S. License Agreement for Lurbinectedin is Effective with the Expiration of the HSR Waiting Period